Friday, August 14, 2009

A 100X change

Aug. 13 (Bloomberg):

Researchers at Massachusetts Institute of Technology and the Broad Institute looked for compounds that could destroy the stem cells, which often resist conventional cancer treatment. One, salinomycin, cut the number of stem cells at least 100 times more than did Bristol-Myers Squibb Co.’s Taxol, a common chemotherapy medicine, according to a report on the findings published today in the journal Cell.

It'll probably take at least 10-15 years before this research results in an working therapeutic medicine. And after some much investment in time, money, and effort, the medicine will be very expensive. Everything is so expensive in healthcare, it's unbelievable. If computers were developed the same way we would still work on IBM mainframes.

No comments: